Venous malformation with localized intravascular coagulopathy in children treated with sclerotherapy and LWMH
Frontiers in Pediatrics · 01.07.2026 · 14
DOI: 10.3389/fped.2026.1835885 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 01.07.2026. Verfasst von Xiao Gao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Localized intravascular coagulopathy (LIC) is a common, underrecognized coagulation complication of pediatric venous malformations (VMs), driven by chronic thrombogenic activation within VM lesions. Developmental hemostatic traits in children may exacerbate LIC severity, but clinical characteristics and optimal management of pediatric LIC remain poorly defined.
Methods
This retrospective cohort study included 116 pediatric VM patients with complete laboratory test results who underwent sclerotherapy at Shandong Provincial Hospital between August 2018 and August 2025. LIC was defined as D-dimer ≥0.60 μg/ml. Chi-square test, Fisher's exact test, Mann-Whitney U test, and correlation analysis were used to explore factors associated with LIC occurrence and severity.
Results
Of 116 patients, 51 (44.8%) had LIC (38 mild, 11 moderate, 2 severe). No significant association was found between LIC (occurrence or severity) and sex, age, or anatomic location. All severe LIC cases occurred in extensive VMs involving ≥2 joint planes. Sclerotherapy combined with low-molecular-weight heparin (LMWH) rapidly corrected coagulation abnormalities in severe LIC.
Discussion
LIC occurrence in pediatric VMs is independent of demographic or anatomic factors, while severity correlates directly with lesion burden. Sclerotherapy is the core intervention for LIC control, with LMWH serving only as perioperative adjuvant therapy. This study supports routine screening for occult VM in unexplained pediatric coagulopathy, providing real-world evidence for optimized clinical management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Förderung
- Natural Science Foundation of Shandong Province
Zitieren
APA
Gao, X., Wang, X., Wei, Y., Niu, S., Yang, L., & Xu, L. (2026). Venous malformation with localized intravascular coagulopathy in children treated with sclerotherapy and LWMH. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1835885
Vancouver
Gao X, Wang X, Wei Y, Niu S, Yang L, Xu L. Venous malformation with localized intravascular coagulopathy in children treated with sclerotherapy and LWMH. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1835885
BibTeX
@article{Gao2026,
author = {Gao, Xiao and Wang, Xuming and Wei, Yuhua and Niu, Shuai and Yang, Le and Xu, Lei},
title = {Venous malformation with localized intravascular coagulopathy in children treated with sclerotherapy and LWMH},
journal = {Frontiers in Pediatrics},
year = {2026},
volume = {14},
doi = {10.3389/fped.2026.1835885}
}
EUVIMED